AEZS, Aeterna Zentaris Inc. AEZS reported that the European Patent Office (EPO) has granted a patent for the use of the ghrelin agonist, AEZS-130, related to methods and kits for use in relation to the diagnosis of growth hormone deficiency (GHD) in a human or animal subject. AGHD affects 35,000 adult Americans, with 6,000 new adult patients diagnosed each year. Growth hormone not only plays an important role in growth from childhood to adulthood, but helps promote good health throughout life. AGHD is usually characterized by low energy levels, decreased strength and exercise tolerance, increased weight or difficulty losing weight, emotional changes, anxiety and impaired sleep. AEZS-130, a ghrelin agonist, is a novel orally-active small molecule that stimulates the secretion of growth hormone. AEZS has completed a Phase 3 trial for use as an oral diagnostic test for AGHD. AEZS-130 has been granted orphan drug designation by the FDA for use in this indication. AEZS-130 is also in a Phase 2A trial as a treatment for cancer-induced cachexia. AEZS owns the worldwide rights to AEZS-130. AEZS is an oncology and endocrinology drug development company currently investigating treatments for various unmet medical needs. More about AEZS at www.aezsinc.com. CPST, Capstone Turbine Corporation CPST reported that it received a follow-on order for five C1000 Power Packages from Genalta Power Inc. in Canada. The initial order from Genalta Power was for three C1000 Power Packages in September 2011. The five Capstone C1000s will be installed at two of Genalta client's natural gas processing plants and will be fueled by natural gas captured from oil and gas flares. Today, a number of refineries, landfills, and wastewater treatment plants flare waste gas into the atmosphere, which increases CO2 gas emissions and global warming. CPST's microturbines are an ideal solution since they use the waste gas to produce reliable and clean renewable energy onsite. CPST is the world's leading producer of low-emission microturbine systems, and was the first to market commercially viable microturbine energy products. More about CPST at www.capstoneturbine.com Online marketing allows consumers of the world to research and purchase services and products at their own pace and convenience. This is massively appealing to the many diverse societies of the world. Crown Equity Holdings Inc., (CRWE) offers advertising branding and marketing services as a worldwide online multi-media publisher with its digital network of websites and focuses on the distribution of information for the purpose of bringing together a targeted audience and the advertisers that want to reach them. CRWEs advertising services cover and connect a range of marketing specialties, as well as provide search engine optimization for clients interested in online media awareness. CRWEs division CRWE AD-Services (www.crwe-adservices.com), is a full service multimedia advertising company specializing in internet marketing. It provides modern and unique advertising campaigns, dedicated to offering the most cost effective advertising solutions. More about CRWE at www.crownequityholdings.com. THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: PennyOmega.com publisher and its affiliates and contractors are not registered investment advisers or broker/dealers. (Read Full Disclaimer at http://pennyomega.com/disclaimer).
